| Particulars |
|
|
|
| Company Name
| Sun Pharmaceutical Industries Ltd
| Year End
| 202403
|
| Full Year |
| Equity (₹ Cr.) |
239.93 |
B.V. (₹) |
98.30 |
| Sales(₹ Cr.) |
20,275.17 |
NP (₹ Cr.) |
3,051.64 |
| NP Var% |
-9.00 |
Div% |
1,350.00 |
| CPS(₹) |
19.40 |
EPS (₹) |
12.70 |
| Traded Value(₹ Lakhs) |
968.12 |
52 Week High |
1,960.00 |
| 52 Week Low |
1,377.00 |
Price BSE |
1,652.00 |
| Price NSE |
1,652.00 |
Market Capital (₹ Cr.) |
396,394.13 |
| P/C Ratio |
85.20 |
P/E Ratio |
129.90 |
| Price Vs.BV |
16.81 |
|
| Latest Quarter |
| Year End |
202412 |
Sales (₹ Cr.) |
5,985.33 |
| NP(₹ Cr.) |
1,181.05 |
NP Var % |
50.00 |
| Trailing Twelve Months |
| Year End |
202412 |
Sales |
19,974.06 |
| OPM |
26.45 |
NP |
2,757.03 |
| NP Var% |
-23.55 |
EPS |
13.13 |
| PE |
125.83 |
|
|